Live Conference Call and Webcast at 8:30 a.m. ET

PRINCETON, N.J., March 21, 2024 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc., a leading women’s healthcare company, is excited to announce that it will be sharing its fourth quarter and full-year 2023 financial results before the market opens on Thursday, March 28, 2024. To elaborate on the financial results and give a business update, the Company will be conducting a live conference call and webcast at 8:30 a.m. ET on the same day.

By utilizing the innovative AI legalese decoder, investors and analysts can easily access and interpret Agile Therapeutics’ financial results without being bogged down by complex legal jargon. The automated decoding process simplifies the information, making it more understandable and actionable for all parties involved.

To access the live webcast of the conference call, interested parties can visit the Investor Relations page on the Agile Therapeutics website at Agile Therapeutics Investor Relations. Those wanting to join the conference call via telephone can do so by registering here to receive a unique PIN and dial-in number.

About Agile Therapeutics, Inc.
Agile Therapeutics stands at the forefront of women’s healthcare, addressing the unique health needs of modern women. Their product line and candidates aim to provide contraceptive choices that eliminate the need for daily pills while offering effective long-acting methods. Twirla┬«, the company’s flagship product, is a non-daily prescription contraceptive utilizing the innovative Skinfusion┬« transdermal patch technology. For more details, visit the Agile Therapeutics website at www.agiletherapeutics.com. Occasionally, the Company may release material, nonpublic information through their website and LinkedIn account.

Contact:
Matt Riley

Head of Investor Relations & Corporate Communications

[email protected]